BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falzone L, Lupo G, La Rosa GRM, Crimi S, Anfuso CD, Salemi R, Rapisarda E, Libra M, Candido S. Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer. Cancers (Basel) 2019;11:E610. [PMID: 31052345 DOI: 10.3390/cancers11050610] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 17.3] [Reference Citation Analysis]
Number Citing Articles
1 Petralia MC, Mazzon E, Basile MS, Cutuli M, Di Marco R, Scandurra F, Saraceno A, Fagone P, Nicoletti F, Mangano K. Effects of Treatment with the Hypomethylating Agent 5-aza-2'-deoxycytidine in Murine Type II Collagen-Induced Arthritis. Pharmaceuticals (Basel) 2019;12:E174. [PMID: 31783688 DOI: 10.3390/ph12040174] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
2 Zhang H, Wang P, Song T, Bonnette UL, Zhang Z. Screening and identification of key genes in imatinib-resistant chronic myelogenous leukemia cells: a bioinformatics study. Hematology 2021;26:408-14. [PMID: 34053416 DOI: 10.1080/16078454.2021.1931740] [Reference Citation Analysis]
3 Wang K, Chen R, Feng Z, Zhu YM, Sun XX, Huang W, Chen ZN. Identification of differentially expressed genes in non-small cell lung cancer. Aging (Albany NY) 2019;11:11170-85. [PMID: 31816603 DOI: 10.18632/aging.102521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Indrieri A, Carrella S, Carotenuto P, Banfi S, Franco B. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer. Int J Mol Sci 2020;21:E2092. [PMID: 32197476 DOI: 10.3390/ijms21062092] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
5 Shen Y, Pu K, Zheng K, Ma X, Qin J, Jiang L, Li J. Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation. Int J Mol Sci 2019;20:E4473. [PMID: 31510100 DOI: 10.3390/ijms20184473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, Kovatsi L, Spandidos DA, Drakoulis N, Kalogeraki A, Mamoulakis C, Tzanakakis G, Libra M, Tsatsakis A. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells 2019;8:E1251. [PMID: 31615102 DOI: 10.3390/cells8101251] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
7 Falzone L, Grimaldi M, Celentano E, Augustin LSA, Libra M. Identification of Modulated MicroRNAs Associated with Breast Cancer, Diet, and Physical Activity. Cancers (Basel) 2020;12:E2555. [PMID: 32911851 DOI: 10.3390/cancers12092555] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
8 Nian X, Chen W, Bai W, Zhao Z, Zhang Y. miR-263b Controls Circadian Behavior and the Structural Plasticity of Pacemaker Neurons by Regulating the LIM-Only Protein Beadex. Cells 2019;8:E923. [PMID: 31426557 DOI: 10.3390/cells8080923] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Filetti V, Loreto C, Falzone L, Lombardo C, Cannizzaro E, Castorina S, Ledda C, Rapisarda V. Diagnostic and Prognostic Value of Three microRNAs in Environmental Asbestiform Fibers-Associated Malignant Mesothelioma. J Pers Med 2021;11:1205. [PMID: 34834557 DOI: 10.3390/jpm11111205] [Reference Citation Analysis]
10 Xu XL, Liu H, Zhang Y, Zhang SX, Chen Z, Bao Y, Li TK. SPP1 and FN1 are significant gene biomarkers of tongue squamous cell carcinoma. Oncol Lett 2021;22:713. [PMID: 34457068 DOI: 10.3892/ol.2021.12974] [Reference Citation Analysis]
11 Zhang Y, Liu X, Zhang J, Xu Y, Shao J, Hu Y, Shu P, Cheng H. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway. Aging (Albany NY) 2020;12:5640-50. [PMID: 32209726 DOI: 10.18632/aging.102929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
12 Larcher LM, Wang T, Veedu RN. Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells. Molecules 2019;24:E2489. [PMID: 31284665 DOI: 10.3390/molecules24132489] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
13 Luo Y, Ge R, Wu H, Ding X, Song H, Ji H, Li M, Ma Y, Li S, Wang C, Du H. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain. Stem Cell Res Ther 2019;10:339. [PMID: 31753039 DOI: 10.1186/s13287-019-1470-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
14 Hamidi F, Gilani N, Belaghi RA, Sarbakhsh P, Edgünlü T, Santaguida P. Exploration of Potential miRNA Biomarkers and Prediction for Ovarian Cancer Using Artificial Intelligence. Front Genet 2021;12:724785. [PMID: 34899827 DOI: 10.3389/fgene.2021.724785] [Reference Citation Analysis]
15 Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS, Libra M, Falzone L. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. Cells 2020;9:E1151. [PMID: 32392801 DOI: 10.3390/cells9051151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
16 Liu Y, Zhou H, Zheng J, Zeng X, Yu W, Liu W, Huang G, Zhang Y, Fu W. Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis. Front Oncol 2020;10:1008. [PMID: 32903590 DOI: 10.3389/fonc.2020.01008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Costa C, Teodoro M, Rugolo CA, Alibrando C, Giambò F, Briguglio G, Fenga C. MicroRNAs alteration as early biomarkers for cancer and neurodegenerative diseases: New challenges in pesticides exposure. Toxicol Rep 2020;7:759-67. [PMID: 32612936 DOI: 10.1016/j.toxrep.2020.05.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
18 Huang ZD, Yao YY, Chen TY, Zhao YF, Zhang C, Niu YM. Construction of Prognostic Risk Prediction Model of Oral Squamous Cell Carcinoma Based on Nine Survival-Associated Metabolic Genes. Front Physiol 2021;12:609770. [PMID: 33815132 DOI: 10.3389/fphys.2021.609770] [Reference Citation Analysis]
19 Moraes FC, Marcelo Forero Ramirez L, Aid R, Benadda S, Maire M, Chauvierre C, Antunes JC, Chaubet F, Letourneur D. P-selectin targeting polysaccharide-based nanogels for miRNA delivery. International Journal of Pharmaceutics 2021;597:120302. [DOI: 10.1016/j.ijpharm.2021.120302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Shaw P, Senthilnathan R, Krishnan S, Suresh D, Shetty S, Muthukaliannan GK, Mani RR, Sivanandy P, Chandramoorthy HCK, Gupta MM, Baxi S, Jayaraj R. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:4369. [PMID: 34503179 DOI: 10.3390/cancers13174369] [Reference Citation Analysis]
21 Peng JL, Wu JZ, Li GJ, Wu JL, Xi YM, Li XQ, Wang L. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24172. [PMID: 33466191 DOI: 10.1097/MD.0000000000024172] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Kaushik AC, Mehmood A, Wei DQ, Dai X. Systems Biology Integration and Screening of Reliable Prognostic Markers to Create Synergies in the Control of Lung Cancer Patients. Front Mol Biosci 2020;7:47. [PMID: 32318583 DOI: 10.3389/fmolb.2020.00047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Linck-Paulus L, Hellerbrand C, Bosserhoff AK, Dietrich P. Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma. Cells 2020;9:E114. [PMID: 31906510 DOI: 10.3390/cells9010114] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
24 Kar K, Fariha A, Hossain MS, Quadery Tonmoy MI, Hami I, Singha Roy A, Kabir Shakil MS, Al Reza H, Mohammed Bahadur N, Rahaman MM. Prediction of novel miRNA biomarker candidates for diagnostic and prognostic analysis of STAD and LIHC: An integrated in silico approach. Informatics in Medicine Unlocked 2021;24:100581. [DOI: 10.1016/j.imu.2021.100581] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Cheng Y, Cheng T, Zhao Y, Qu Y. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma. Cell Signal 2019;63:109386. [PMID: 31394192 DOI: 10.1016/j.cellsig.2019.109386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
26 Xu C, Meng LB, Duan YC, Cheng YJ, Zhang CM, Zhou X, Huang CB. Screening and identification of biomarkers for systemic sclerosis via microarray technology. Int J Mol Med 2019;44:1753-70. [PMID: 31545397 DOI: 10.3892/ijmm.2019.4332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current Perspectives in Cancer Immunotherapy. Cancers (Basel) 2019;11:E1472. [PMID: 31575023 DOI: 10.3390/cancers11101472] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 21.3] [Reference Citation Analysis]
28 Hong BS. Regulation of the Effect of Physical Activity Through MicroRNAs in Breast Cancer. Int J Sports Med 2021. [PMID: 34872116 DOI: 10.1055/a-1678-7147] [Reference Citation Analysis]
29 Crimi S, Falzone L, Gattuso G, Grillo CM, Candido S, Bianchi A, Libra M. Droplet Digital PCR Analysis of Liquid Biopsy Samples Unveils the Diagnostic Role of hsa-miR-133a-3p and hsa-miR-375-3p in Oral Cancer. Biology (Basel) 2020;9:E379. [PMID: 33172167 DOI: 10.3390/biology9110379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
30 Li L, Feng T, Zhang W, Gao S, Wang R, Lv W, Zhu T, Yu H, Qian B. MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer. Int J Genomics 2020;2020:7415909. [PMID: 31976313 DOI: 10.1155/2020/7415909] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
31 Jhan JH, Hsu WC, Lee YC, Li WM, Huang AM, Lin HH, Wang CS, Wu YR, Li CC, Wu WJ, Ke HL. MicroRNA-375-3p Suppresses Upper Tract Urothelial Carcinoma Cell Migration and Invasion via Targeting Derlin-1. Cancers (Basel) 2022;14:880. [PMID: 35205628 DOI: 10.3390/cancers14040880] [Reference Citation Analysis]
32 Candido S, Lupo G, Pennisi M, Basile MS, Anfuso CD, Petralia MC, Gattuso G, Vivarelli S, Spandidos DA, Libra M, Falzone L. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Oncol Rep 2019;42:911-22. [PMID: 31322245 DOI: 10.3892/or.2019.7215] [Cited by in Crossref: 34] [Cited by in F6Publishing: 48] [Article Influence: 11.3] [Reference Citation Analysis]
33 Nováková T, Macháčková T, Novák J, Hude P, Godava J, Žampachová V, Oppelt J, Zlámal F, Němec P, Bedáňová H, Slabý O, Bienertová-Vašků J, Špinarová L, Krejčí J. Identification of a Diagnostic Set of Endomyocardial Biopsy microRNAs for Acute Cellular Rejection Diagnostics in Patients after Heart Transplantation Using Next-Generation Sequencing. Cells 2019;8:E1400. [PMID: 31698874 DOI: 10.3390/cells8111400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Zhang X, Ma L, Zhai L, Chen D, Li Y, Shang Z, Zhang Z, Gao Y, Yang W, Li Y, Pan Y. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Int J Med Sci 2021;18:984-99. [PMID: 33456356 DOI: 10.7150/ijms.49126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Tu F, Li M, Chen Y, Chu H, Wang S, Hai L, Xie T, Geng F, Zhao T, Wang Q, Feng Z. Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1. Open Medicine 2022;17:1019-30. [DOI: 10.1515/med-2022-0499] [Reference Citation Analysis]
36 Siokas V, Aslanidou P, Aloizou A, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease? J Mol Neurosci 2020;70:851-60. [DOI: 10.1007/s12031-020-01507-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
37 Vivarelli S, Falzone L, Basile MS, Candido S, Libra M. Nitric Oxide in Hematological Cancers: Partner or Rival? Antioxid Redox Signal 2021;34:383-401. [PMID: 32027171 DOI: 10.1089/ars.2019.7958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
38 Nikolouzakis TK, Falzone L, Lasithiotakis K, Krüger-Krasagakis S, Kalogeraki A, Sifaki M, Spandidos DA, Chrysos E, Tsatsakis A, Tsiaoussis J. Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer. J Clin Med 2020;9:E2868. [PMID: 32899768 DOI: 10.3390/jcm9092868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
39 Teodoro M, Briguglio G, Fenga C, Costa C. Genetic polymorphisms as determinants of pesticide toxicity: Recent advances. Toxicol Rep 2019;6:564-70. [PMID: 31293901 DOI: 10.1016/j.toxrep.2019.06.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
40 Brenner C. Applications of Bioinformatics in Cancer. Cancers (Basel) 2019;11:E1630. [PMID: 31652939 DOI: 10.3390/cancers11111630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Huang W, Yan YG, Wang WJ, Ouyang ZH, Li XL, Zhang TL, Wang XB, Wang B, Lv GH, Li J, Zou MX. Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma. Front Oncol 2020;10:556902. [PMID: 33194623 DOI: 10.3389/fonc.2020.556902] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Guo Z, Han L, Fu Y, Wu Z, Ma Y, Li Y, Wang H, Jiang L, Liang S, Wang Z, Li F, Xiao W, Wang J, Wang Y. Systematic Evaluation of the Diagnostic and Prognostic Significance of Competitive Endogenous RNA Networks in Prostate Cancer. Front Genet 2020;11:785. [PMID: 32849794 DOI: 10.3389/fgene.2020.00785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Lombardo SD, Mazzon E, Basile MS, Campo G, Corsico F, Presti M, Bramanti P, Mangano K, Petralia MC, Nicoletti F, Fagone P. Modulation of Tetraspanin 32 (TSPAN32) Expression in T Cell-Mediated Immune Responses and in Multiple Sclerosis. Int J Mol Sci 2019;20:E4323. [PMID: 31487788 DOI: 10.3390/ijms20184323] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
44 Zheng Y, Song A, Zhou Y, Zhong Y, Zhang W, Wang C, Ding X, Du Y, Zhang W, Li G, Wu H, Wu Y, Song X. Identification of extracellular vesicles-transported miRNAs in Erlotinib-resistant head and neck squamous cell carcinoma. J Cell Commun Signal 2020;14:389-402. [PMID: 32157550 DOI: 10.1007/s12079-020-00546-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
45 Chen YT, Wong LL, Liew OW, Richards AM. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs. Cells 2019;8:E1651. [PMID: 31888288 DOI: 10.3390/cells8121651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
46 Ye X, Gao Q, Wu J, Zhou L, Tao M. Identification of significant genes in non-small cell lung cancer by bioinformatics analyses. Transl Cancer Res 2020;9:4330-40. [PMID: 35117799 DOI: 10.21037/tcr-19-2596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Moraes FC, Antunes JC, Forero Ramirez LM, Aprile P, Franck G, Chauvierre C, Chaubet F, Letourneur D. Synthesis of cationic quaternized pullulan derivatives for miRNA delivery. Int J Pharm 2020;577:119041. [PMID: 31978463 DOI: 10.1016/j.ijpharm.2020.119041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
48 Vivarelli S, Falzone L, Basile M, Nicolosi D, Genovese C, Libra M, Salmeri M. Benefits of using probiotics as adjuvants in anticancer therapy (Review). Wrld Acd Sci 2019. [DOI: 10.3892/wasj.2019.13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Jiang Q, Xue D, Shi F, Qiu J. Prognostic significance of an autophagy-related long non-coding RNA signature in patients with oral and oropharyngeal squamous cell carcinoma. Oncol Lett 2021;21:29. [PMID: 33240435 DOI: 10.3892/ol.2020.12290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Andl T, Ganapathy K, Bossan A, Chakrabarti R. MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology? Int J Mol Sci 2020;21:E4796. [PMID: 32645914 DOI: 10.3390/ijms21134796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Moraes FC, Pichon C, Letourneur D, Chaubet F. miRNA Delivery by Nanosystems: State of the Art and Perspectives. Pharmaceutics 2021;13:1901. [PMID: 34834316 DOI: 10.3390/pharmaceutics13111901] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019;8:E863. [PMID: 31405017 DOI: 10.3390/cells8080863] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 20.7] [Reference Citation Analysis]
53 Sato C, Osakabe M, Nagasawa T, Suzuki H, Itamochi H, Baba T, Sugai T. Genome-wide analysis of microRNA to evaluate prognostic markers in isolated cancer glands and surrounding stroma in high-grade serous ovarian carcinoma. Oncol Lett 2020;20:338. [PMID: 33123249 DOI: 10.3892/ol.2020.12198] [Reference Citation Analysis]
54 La Rosa GRM, Gattuso G, Pedullà E, Rapisarda E, Nicolosi D, Salmeri M. Association of oral dysbiosis with oral cancer development. Oncol Lett 2020;19:3045-58. [PMID: 32211076 DOI: 10.3892/ol.2020.11441] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
55 Liang H, Xu M, Xiong Z, Hu K, Yang J, Cao M, Zhong Z, Yao Z, Deng M, Liu B. Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma. Aging (Albany NY) 2021;13:6115-33. [PMID: 33617479 DOI: 10.18632/aging.202606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Asanomi Y, Shigemizu D, Akiyama S, Sakurai T, Ozaki K, Ochiya T, Niida S. Dementia subtype prediction models constructed by penalized regression methods for multiclass classification using serum microRNA expression data. Sci Rep 2021;11:20947. [PMID: 34686734 DOI: 10.1038/s41598-021-00424-1] [Reference Citation Analysis]
57 Shi Y, Yan F, Wang F, Pan L. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Tissue Cell 2021;72:101534. [PMID: 33991762 DOI: 10.1016/j.tice.2021.101534] [Reference Citation Analysis]
58 Zhang Y, Qin X, Jiang J, Zhao W. MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway. Oncol Lett 2020;20:1327-35. [PMID: 32724375 DOI: 10.3892/ol.2020.11687] [Reference Citation Analysis]
59 Dai ZT, Xiang Y, Wang Y, Bao LY, Wang J, Li JP, Zhang HM, Lu Z, Ponnambalam S, Liao XH. Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer. Aging (Albany NY) 2021;13:13876-97. [PMID: 33962392 DOI: 10.18632/aging.202982] [Reference Citation Analysis]
60 Cicciù M, Cervino G, Fiorillo L, D'Amico C, Oteri G, Troiano G, Zhurakivska K, Lo Muzio L, Herford AS, Crimi S, Bianchi A, Di Stasio D, Rullo R, Laino G, Laino L. Early Diagnosis on Oral and Potentially Oral Malignant Lesions: A Systematic Review on the VELscope® Fluorescence Method. Dent J (Basel) 2019;7:E93. [PMID: 31487927 DOI: 10.3390/dj7030093] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
61 Jin W, Han H, Liu D. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells. CBM 2019;26:183-91. [DOI: 10.3233/cbm-190384] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
62 Cai P, Zheng H, She J, Feng N, Zou H, Gu J, Yuan Y, Liu X, Liu Z, Bian J. Molecular Mechanism of Aflatoxin-Induced Hepatocellular Carcinoma Derived from a Bioinformatics Analysis. Toxins (Basel) 2020;12:E203. [PMID: 32210020 DOI: 10.3390/toxins12030203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]